Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guo-Ming Shi

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
American Journal of Translational Research|January 22, 2019
Reduced selenium-binding protein 1 correlates with a poor prognosis in intrahepatic cholangiocarcinoma and promotes the cell epithelial-mesenchymal transitionXin-Yu Zhang, Ping-Ting Gao, Xuan Yang, et al.
Biomarker Research|April 26, 2022
KSR2-14-3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinomaChao Gao, Si-Wei Wang, Jia-Cheng Lu, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 7, 2019
Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinomaRui Peng, Peng-Fei Zhang, Xuan Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2013
Margin-infiltrating CD20(+) B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinomaJie-Yi Shi, Qiang Gao, Zhi-Chao Wang, et al.
Hepatology (Baltimore, Md.)|June 26, 2010
CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinomaGuo-Ming Shi, Ai-Wu Ke, Jian Zhou, et al.
Gut|April 20, 2026
Norepinephrine promotes tumour cell aggressiveness and NK cell ferroptosis via ADRB2 in intrahepatic cholangiocarcinoma with perineural invasionXian-Long Meng, Jia-Cheng Lu, Yi-Xiao Zhang, et al.
The Journal of Pathology|September 27, 2014
CC chemokine receptor-like 1 functions as a tumour suppressor by impairing CCR7-related chemotaxis in hepatocellular carcinomaJie-Yi Shi, Liu-Xiao Yang, Zhi-Chao Wang, et al.
Hepatology (Baltimore, Md.)|December 10, 2008
Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinomaAi-Wu Ke, Guo-Ming Shi, Jian Zhou, et al.
Annals of Translational Medicine|November 19, 2020
Adjuvant apatinib treatment after resection of hepatocellular carcinoma with portal vein tumor thrombosis: a phase II trialHui-Chuan Sun, Xiao-Dong Zhu, Jian Zhou, et al.
Cancer Research|June 20, 2012
CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinomaQiang Gao, Ying-Jun Zhao, Xiao-Ying Wang, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
American Journal of Translational Research|January 22, 2019
Reduced selenium-binding protein 1 correlates with a poor prognosis in intrahepatic cholangiocarcinoma and promotes the cell epithelial-mesenchymal transitionXin-Yu Zhang, Ping-Ting Gao, Xuan Yang, et al.
Biomarker Research|April 26, 2022
KSR2-14-3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinomaChao Gao, Si-Wei Wang, Jia-Cheng Lu, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 7, 2019
Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinomaRui Peng, Peng-Fei Zhang, Xuan Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2013
Margin-infiltrating CD20(+) B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinomaJie-Yi Shi, Qiang Gao, Zhi-Chao Wang, et al.
Hepatology (Baltimore, Md.)|June 26, 2010
CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinomaGuo-Ming Shi, Ai-Wu Ke, Jian Zhou, et al.
Gut|April 20, 2026
Norepinephrine promotes tumour cell aggressiveness and NK cell ferroptosis via ADRB2 in intrahepatic cholangiocarcinoma with perineural invasionXian-Long Meng, Jia-Cheng Lu, Yi-Xiao Zhang, et al.
The Journal of Pathology|September 27, 2014
CC chemokine receptor-like 1 functions as a tumour suppressor by impairing CCR7-related chemotaxis in hepatocellular carcinomaJie-Yi Shi, Liu-Xiao Yang, Zhi-Chao Wang, et al.
Hepatology (Baltimore, Md.)|December 10, 2008
Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinomaAi-Wu Ke, Guo-Ming Shi, Jian Zhou, et al.
Annals of Translational Medicine|November 19, 2020
Adjuvant apatinib treatment after resection of hepatocellular carcinoma with portal vein tumor thrombosis: a phase II trialHui-Chuan Sun, Xiao-Dong Zhu, Jian Zhou, et al.
Cancer Research|June 20, 2012
CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinomaQiang Gao, Ying-Jun Zhao, Xiao-Ying Wang, et al.
Pageof 10